TENGEN BIOMEDICAL COMPANY has a total of 11 patent applications. Its first patent ever was published in 2005. It filed its patents most often in China, United States and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are SNIPR BIOME APS, ANIMAL VACCINE RESEARCH CORP and GUANGDONG XTEM BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 2 | |
#2 | United States | 2 | |
#3 | Brazil | 1 | |
#4 | Cuba | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Philippines | 1 | |
#8 | Singapore | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Climate change adaptation technologies | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Pang Xiaowu | 9 |
#2 | Gu Xinbin | 9 |
#3 | Pang Xiaowa | 1 |
#4 | Xiaowu Pang | 1 |
#5 | Xinbin Gu | 1 |
Publication | Filing date | Title |
---|---|---|
CN111343998A | Mammalian-specific growth-deficient arbovirus | |
US2009197319A1 | Virus-Like Particle Containing A Dengue Recombinant Replicon | |
CN101018860A | Flavivirus vaccine |